You are here

  • Home
  • Archive
  • Volume 33, Issue Suppl 4
  • TP012/#1530  Phase 2, single arm clinical trial to evaluate the safety and activity of oregovomab and niraparib in subjects with platinum sensitive recurrent ovarian cancer: flora-4

Article info

Article menu

Download PDFPDF

ePoster Viewing: Trials-in-Progress
AS11. Ovarian cancer
TP012/#1530  Phase 2, single arm clinical trial to evaluate the safety and activity of oregovomab and niraparib in subjects with platinum sensitive recurrent ovarian cancer: flora-4
Free

Authors

Citation

Duska L, Richardson D, Jada SR, et al
TP012/#1530  Phase 2, single arm clinical trial to evaluate the safety and activity of oregovomab and niraparib in subjects with platinum sensitive recurrent ovarian cancer: flora-4
International Journal of Gynecologic Cancer 2023;33:A251.

Publication history

  • First published November 7, 2023.
Online issue publication 
November 07, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.